SCHEMBL3839629

SCHEMBL3839629

C[Si](C)(Cc1ccccc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.59
NR1H3 Q13133 2/20 0.59
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
CALM1 P0DP23 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
TSHR P16473 4/20 0.37
ALDH1A1 P00352 3/20 0.37
IDO1 P14902 1/20 0.36
LOXL2 Q9Y4K0 1/20 0.36
TRPA1 O75762 1/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8045525 0.98 NR1H2 (0.58) NR1H2NR1H3MAPTTP53CALM1
SCHEMBL988388 0.87 NR1H2 (0.49) NR1H2NR1H3MAPTTP53TSHR
SCHEMBL8441765 0.85 NR1H2 (0.47) NR1H2NR1H3MAPTTP53ESR1
SCHEMBL8755369 0.85 NR1H2 (0.47) NR1H2NR1H3MAPTTP53ESR1
SCHEMBL15863715 0.85 NR1H2 (0.51) NR1H2NR1H3MAPTTP53CALM1
SCHEMBL14968791 0.80 NR1H2 (0.47) NR1H2NR1H3MAPTESR1ESR2
SCHEMBL6264576 0.80 NR1H2 (0.42) NR1H2NR1H3MAPTTP53CALM1
SCHEMBL21870365 0.78 NR1H2 (0.42) NR1H2NR1H3MAPT
SCHEMBL4682428 0.76 NR1H2 (0.40) NR1H2NR1H3MAPTTP53CALM1
SCHEMBL9223926 0.76 TDP1 (0.46) NR1H2NR1H3MAPTTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023222245-A1 PROCESS FOR PRODUCING ORGANOSILICON COMPOUNDS WACKER CHEMIE AG (DE) 2023-11-23 WO disclosed
EP-0861247-B1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS AVENTIS PHARMA SA (FR) 2009-10-07 EP disclosed
EP-0858459-B1 NOVEL ACID PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR, USE THEREOF AS DRUGS, NOVEL USE THEREFOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH DERIVATIVES AVENTIS PHARMA SA (FR) 2002-09-04 EP disclosed
EP-0861247-A1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS HOECHST MARION ROUSSEL (FR) 1998-09-02 EP disclosed
EP-0858459-A1 NOVEL ACID PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR, USE THEREOF AS DRUGS, NOVEL USE THEREFOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH DERIVATIVES HOECHST MARION ROUSSEL (FR) 1998-08-19 EP disclosed
WO-1997017339-A1 NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS HOECHST MARION ROUSSEL (FR) 1997-05-15 WO disclosed
WO-1997015570-A1 NOVEL ACID PYRAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR, USE THEREOF AS DRUGS, NOVEL USE THEREFOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH DERIVATIVES HOECHST MARION ROUSSEL (FR) 1997-05-01 WO disclosed